These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 37192858)

  • 41. Following the messenger: Recent innovations in live cell single molecule fluorescence imaging.
    Schmidt A; Gao G; Little SR; Jalihal AP; Walter NG
    Wiley Interdiscip Rev RNA; 2020 Jul; 11(4):e1587. PubMed ID: 31990126
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Site-Specific m
    Xu Y; Wang Y; Liang FS
    Angew Chem Int Ed Engl; 2023 Oct; 62(43):e202309291. PubMed ID: 37713087
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Applications of the versatile CRISPR-Cas13 RNA targeting system.
    Kordyś M; Sen R; Warkocki Z
    Wiley Interdiscip Rev RNA; 2022 May; 13(3):e1694. PubMed ID: 34553495
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Advances in the RNA-targeting CRISPR-Cas systems].
    Hong T; Luo Q
    Sheng Wu Gong Cheng Xue Bao; 2023 Apr; 39(4):1363-1373. PubMed ID: 37154311
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Multiplexed Gene Engineering Based on dCas9 and gRNA-tRNA Array Encoded on Single Transcript.
    Jiang C; Geng L; Wang J; Liang Y; Guo X; Liu C; Zhao Y; Jin J; Liu Z; Mu Y
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37239880
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Visualization of specific DNA sequences in living mouse embryonic stem cells with a programmable fluorescent CRISPR/Cas system.
    Anton T; Bultmann S; Leonhardt H; Markaki Y
    Nucleus; 2014; 5(2):163-72. PubMed ID: 24637835
    [TBL] [Abstract][Full Text] [Related]  

  • 47. crRNA and tracrRNA guide Cas9-mediated DNA interference in Streptococcus thermophilus.
    Karvelis T; Gasiunas G; Miksys A; Barrangou R; Horvath P; Siksnys V
    RNA Biol; 2013 May; 10(5):841-51. PubMed ID: 23535272
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Visualization of Single mRNAs in Live Neurons.
    Shim JY; Lee BH; Park HY
    Methods Mol Biol; 2019; 2038():47-61. PubMed ID: 31407277
    [TBL] [Abstract][Full Text] [Related]  

  • 49. CRISPR-Cas13-Mediated Knockdown of Regulator of G-Protein Signaling 8 (RGS8) Does Not Affect Purkinje Cell Dendritic Development.
    Wu QW; Kapfhammer JP
    Front Cell Dev Biol; 2022; 10():854273. PubMed ID: 35712654
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A target expression threshold dictates invader defense and prevents autoimmunity by CRISPR-Cas13.
    Vialetto E; Yu Y; Collins SP; Wandera KG; Barquist L; Beisel CL
    Cell Host Microbe; 2022 Aug; 30(8):1151-1162.e6. PubMed ID: 35690065
    [TBL] [Abstract][Full Text] [Related]  

  • 51. RNA-protein interaction mapping via MS2- or Cas13-based APEX targeting.
    Han S; Zhao BS; Myers SA; Carr SA; He C; Ting AY
    Proc Natl Acad Sci U S A; 2020 Sep; 117(36):22068-22079. PubMed ID: 32839320
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dynamic imaging of genomic loci in living human cells by an optimized CRISPR/Cas system.
    Chen B; Gilbert LA; Cimini BA; Schnitzbauer J; Zhang W; Li GW; Park J; Blackburn EH; Weissman JS; Qi LS; Huang B
    Cell; 2013 Dec; 155(7):1479-91. PubMed ID: 24360272
    [TBL] [Abstract][Full Text] [Related]  

  • 53. CRISPR-Cas13 technology portfolio and alliance with other genetic tools.
    Wu S; Tian P; Tan T
    Biotechnol Adv; 2022 Dec; 61():108047. PubMed ID: 36208845
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Programmable RNA targeting with the single-protein CRISPR effector Cas7-11.
    Özcan A; Krajeski R; Ioannidi E; Lee B; Gardner A; Makarova KS; Koonin EV; Abudayyeh OO; Gootenberg JS
    Nature; 2021 Sep; 597(7878):720-725. PubMed ID: 34489594
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Visualizing RNA in Live Bacterial Cells Using Fluorophore- and Quencher-Binding Aptamers.
    Sunbul M; Arora A; Jäschke A
    Methods Mol Biol; 2018; 1649():289-304. PubMed ID: 29130205
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Development and application of sensitive, specific, and rapid CRISPR-Cas13-based diagnosis.
    Shihong Gao D; Zhu X; Lu B
    J Med Virol; 2021 Jul; 93(7):4198-4204. PubMed ID: 33599292
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genetic determinants of PAM-dependent DNA targeting and pre-crRNA processing in Sulfolobus islandicus.
    Peng W; Li H; Hallstrøm S; Peng N; Liang YX; She Q
    RNA Biol; 2013 May; 10(5):738-48. PubMed ID: 23392249
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A rapid and efficient platform for antiviral crRNA screening using CRISPR-Cas13a-based nucleic acid detection.
    Yang L; Zhang Y; Yi W; Dong X; Niu M; Song Y; Han Y; Li H; Sun Y
    Front Immunol; 2023; 14():1116230. PubMed ID: 37228594
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Light-up RNA aptamer signaling-CRISPR-Cas13a-based mix-and-read assays for profiling viable pathogenic bacteria.
    Zhang T; Zhou W; Lin X; Khan MR; Deng S; Zhou M; He G; Wu C; Deng R; He Q
    Biosens Bioelectron; 2021 Mar; 176():112906. PubMed ID: 33342694
    [TBL] [Abstract][Full Text] [Related]  

  • 60. CBRPP: a new RNA-centric method to study RNA-protein interactions.
    Li Y; Liu S; Cao L; Luo Y; Du H; Li S; Zhang Z; Guo X; Tian W; Wong CC; You F
    RNA Biol; 2021 Nov; 18(11):1608-1621. PubMed ID: 33596778
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.